The propaganda for reform in proprietary medicines / [Council on Pharmacy and Chemistry of the American Medical Assoication].

Date:
[1910?]
Catalogue details

Licence: In copyright

Credit: The propaganda for reform in proprietary medicines / [Council on Pharmacy and Chemistry of the American Medical Assoication]. Source: Wellcome Collection.

    41/294 page 41
    Tablets No. XXX (Original bottle).’” As the name is on the bottle, it is not unbelievable that, as the company says in its prospectus, because of “our method of advertising, a large and very profitable business is being created.” That the L. D. Johns Company expects to profit by the self-drugging which this method of prescribing fosters is evident: “Physicians not stockholders in this company suffer from the continual refilling of their prescriptions and from the recommenda- tion of the preparation prescribed by patients to others. [Italics ours.—EpD.] Our stockholders benefit by the refilling of their pre- scriptions and by these recommendations.”’ Put baldly the case amounts to this: Physicians who pre- _seribe “Dr. Johns’ Tablets” not only are likely to foster self- drugging, but they. will reap dividends therefrom. Truly a nice business to be in! } While Bell & Company and the L. D. Johns Company are said to be entirely distinct, they are to be found at the same address at Orangeburg, New York, and as will be seen, the officers of the two companies are more or less related. BELL & CO. L. D. JOHN CO. PRESIDENT ~- - JoHN LL. DODGE - PRESIDENT SECRETARY - - Geo. C. TENNANT VICE-PRESIDENT VICE-PRESIDENT - CHAS. B. SmMitrH - SuEc’y & TREASURER EXPLOITING THE PROFESSION Nostrum promoters have two simple ways of “working” the medical profession. The first—and the more profitable— is, by lavish distribution of free samples, to get physicians to prescribe the blown-in-the-glass “original package” with the inevitable result of large sales direct to the laity. By the second method, which is merely a modification of the first, the physician furnishes the capital for floating the nostrum and then takes his share of the resulting profits. There may not be quite as much money in the second method for the promo- ter, but then the risks are correspondingly less. If the firm fails, the stockholders are the losers; the promoter is not necessarily “out” anything. From a commercial standpoint, a combination of the two methods is, of course, ideal. PEPSIN AND PANCREATIN Report of the Council on Pharmacy and Chemistry (Abstracted from The Journal A. M. A., Feb. 2, 1907, 434) In this report of the Council on Pharmacy and Chemistry attention was called to the incompatibility of pancreatin and pepsin. There are a large number of preparations claiming
    digitised image 1
    digitised image 2
    digitised image 3